Toxicity and side-effects of combination chemohormonal therapy of advanced breast cancer.
J Indian Med Assoc
;
1992 Feb; 90(2): 39-42
Artigo
em Inglês
| IMSEAR
| ID: sea-97345
ABSTRACT
Seventy-five female patients suffering from advanced breast cancer were treated with toilet mastectomy, radiotherapy and oophorectomy (if premenopausal) or tamoxifen therapy (if postmenopausal) as well as chemotherapy with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone. The most common side-effects of combined chemohormonal therapy were gastro-intestinal (nausea, vomiting, rarely diarrhoea) in 43 patients (57.3%), followed by alopecia in 23 patients (30.6%), myelosuppression in 12 patients (16%), extravasation and thrombophlebitis in 7 patients (9.3%), and mucositis and oral erythema in 3 patients (4%). Side-effects of tamoxifen therapy such as vaginal discharge, bleeding, hot flushes were encountered in 10 patients (13.3%). Hypercalcaemia, tumour flare and hepatic, renal, cardiac, pulmonary and neurological toxicities were not encountered. Improvement of 10-30% in Karnofsky performance status was noted in responders while 20-30% deterioration was observed in non-responders. Combination therapy was mostly well tolerated, side-effects were few and toxicities were temporary and reversible.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Assunto principal:
Tamoxifeno
/
Tromboflebite
/
Vômito
/
Neoplasias da Mama
/
Feminino
/
Humanos
/
Prednisona
/
Ovariectomia
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Metotrexato
Idioma:
Inglês
Revista:
J Indian Med Assoc
Ano de publicação:
1992
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS